Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.
Saved in:
| Title: | Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice. |
|---|---|
| Authors: | Conde E; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France.; Neovacs SA, Paris, France., Bertrand R; Neovacs SA, Paris, France., Balbino B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France., Bonnefoy J; Neovacs SA, Paris, France., Stackowicz J; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France., Caillot N; Neovacs SA, Paris, France., Colaone F; Neovacs SA, Paris, France., Hamdi S; Neovacs SA, Paris, France., Houmadi R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Loste A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Kamphuis JBJ; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Huetz F; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France., Guilleminault L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.; Department of respiratory medicine, Toulouse University Hospital, Faculty of Medicine, Toulouse, France., Gaudenzio N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Mougel A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Hardy D; Institut Pasteur, Experimental Neuropathology Unit, Paris, France., Snouwaert JN; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Koller BH; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Serra V; Neovacs SA, Paris, France., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France., Grouard-Vogel G; Neovacs SA, Paris, France., Reber LL; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France. laurent.reber@inserm.fr.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France. laurent.reber@inserm.fr. |
| Source: | Nature communications [Nat Commun] 2021 May 11; Vol. 12 (1), pp. 2574. Date of Electronic Publication: 2021 May 11. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
